Reported covered position: Personal Assistant, Sen. Feinstein (D-CA)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2026 · third_quarter · Q3
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), expanded access to pre-exposure prophylaxis (PrEP) medications and related support; and Federal policy related to 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via
Source: Senate LDA
| SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) | 14 | 2022–2024 |
| NMAC | 11 | 2022–2026 |
| INFINEON TECHNOLOGIES NORTH AMERICA CORP | 10 | 2008–2018 |
| FELD ENTERTAINMENT, INC. | 9 | 2015–2017 |
| OMEGA PROTEIN INC | 5 | 2015–2016 |
| PET PROTEINS LLC D.B.A. ROAM PETS | 5 | 2021 |
| TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) | 5 | 2024–2025 |
| FUR INDUSTRIES OF NORTH AMERICA (FINA) F/K/A FUR WRAPS THE HILL | 4 | 2023–2024 |
| SUNTEX MARINAS | 4 | 2026 |
| DIGITAL SOVEREIGNTY ALLIANCE (DSA) | 3 | 2025 |
| CALISSON INC. | 2 | 2021 |
| FRASIER ENTERPRISES | 2 | 2017 |
| HOMETOWN VETERANS MEDICAL, LLC | 2 | 2023 |
| AMERICAN FUR COUNCIL F/K/A FUR INFORMATION COUNCIL OF AMERICA | 1 | 2024 |
| FUR COMMISSION USA | 1 | 2024 |
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Reentry Act of 2025
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
Reentry Act of 2025
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Reentry Act of 2025
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Patients Deserve Price Tags Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Patients Deserve Price Tags Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Consolidated Appropriations Act, 2026
Client: PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Firm: KELLEY DRYE & WARREN LLP
H.R. 7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Consolidated Appropriations Act, 2026
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
H.R. 7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Consolidated Appropriations Act, 2026
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Enhancing CLIA Act of 2026
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), expanded access to pre-exposure prophylaxis (PrEP) medications and related support; and Federal policy related to 340B.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: NMAC · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: NMAC · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NMAC · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: NMAC · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Firm: KELLEY DRYE & WARREN LLP
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), expanded access to pre-exposure prophylaxis (PrEP) medications and related support; and Federal policy related to 340B.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Lower Costs, More Transparency Act of 2026
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Lower Costs, More Transparency Act of 2026
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Health Care Price Certainty for All Americans Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
SOIL Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
SOIL Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
SOIL Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
PEER Support Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Patients Deserve Price Tags Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Patients Deserve Price Tags Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
RESULTS Act
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
No Red Tape For Addiction Treatment Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
No Red Tape For Addiction Treatment Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
No Red Tape For Addiction Treatment Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
WORK to Save Lives Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
PLOT Act of 2026
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
PLOT Act of 2026
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
PLOT Act of 2026
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; and Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139;
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Sections 70301, 70302, 70412(b), and 70603 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to extension of bonus depreciation under Internal Revenue Code Section 168(k), immediate deductibility of domestic research and development expenses under Internal Revenue Code Section 174, individual deductibility of employer-funded tuition assistance under Internal Revenue Code Section 127, and executive compensation under Internal Revenue Code Section 162(m), respectively; Title VII, Subtitle A, Chapter 3, Subchapter B of such Act, provisions relating to treatment of tax credits and reporting simplification under international tax law and guidance; and federal policy relating to income tax rates for corporations and income tax deductibility of corporate state and local taxes
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Sections 70301, 70302, 70412(b), and 70603 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to extension of bonus depreciation under Internal Revenue Code Section 168(k), immediate deductibility of domestic research and development expenses under Internal Revenue Code Section 174, individual deductibility of employer-funded tuition assistance under Internal Revenue Code Section 127, and executive compensation under Internal Revenue Code Section 162(m), respectively; Title VII, Subtitle A, Chapter 3, Subchapter B of such Act, provisions relating to treatment of tax credits and reporting simplification under international tax law and guidance; and federal policy relating to income tax rates for corporations and income tax deductibility of corporate state and local taxes
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: LABORATORY CORPORATION OF AMERICA HOLDINGS · Firm: KELLEY DRYE & WARREN LLP
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; and Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139;
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Protecting America’s Agricultural Land from Foreign Harm Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
General issues relating to substance use prevention and treatment, including: Reentry Act (not yet introduced); Due Process and Continuity of Care Act (H.R. 1510); Modernizing Opioid Treatment Access Act (not yet introduced); the Support for Patients and Communities Reauthorization Act (H.R. 2483); and related provisions in FY25 continuing resolution (H.R. 1968)
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); PEER Support Act (H.R. 2741 / S. 1329); No Red Tape For Addiction Treatment Act (S. 3522); and WORK To Save Lives Act (draft legislation in House and Senate); FY2026 appropriations language related to substance use prevention and treatment
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (draft bill); H.R. 1510, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); and H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill)
Due Process Continuity of Care Act
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); and H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); FY2026 appropriations language related to substance use prevention and treatment
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Farmland Security Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
FARMLAND Act of 2025
Client: AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) · Firm: KELLEY DRYE & WARREN LLP
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
General issues relating to substance use prevention and treatment, including: Reentry Act (not yet introduced); Due Process and Continuity of Care Act (H.R. 1510); Modernizing Opioid Treatment Access Act (not yet introduced); the Support for Patients and Communities Reauthorization Act (H.R. 2483); and related provisions in FY25 continuing resolution (H.R. 1968)
SUPPORT for Patients and Communities Reauthorization Act of 2025
Client: TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) · Firm: KELLEY DRYE & WARREN LLP
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); PEER Support Act (H.R. 2741 / S. 1329); No Red Tape For Addiction Treatment Act (S. 3522); and WORK To Save Lives Act (draft legislation in House and Senate); FY2026 appropriations language related to substance use prevention and treatment
2026 · third_quarter · Q3
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2026 · third_quarter · Q3
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2026 · third_quarter · Q3
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNTEX MARINAS via KELLEY DRYE & WARREN LLP
2026 · third_quarter · Q3
Water Resources Development Act of 2026; provisions relating to administration of lease concessions on US Army Corp of Engineers-managed lakes, canals, and rivers
Filing targets: Army, Dept of (Corps of Engineers), HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2026 · third_quarter · Q3
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). FY2027 Labor HHS Appropriations bill (H.R. 9260, no Senate bill), provisions relating to substance use prevention and treatment funding and policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
H.R. 9260 (no Senate bill) LHHSED Appropriations Act and H.R. 9170 (no Senate bill) T-HUD Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, and H.R. 9393, the Lower Costs, More Transparency Act, provisions relating to lab test price transparency; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. Agricultural Act of 2026 (Draft bill) provisions relating to the Agricultural Foreign Investment Disclosure Act U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
SUNTEX MARINAS via KELLEY DRYE & WARREN LLP
2026 · second_quarter · Q2
Water Resources Development Act of 2026; provisions relating to administration of lease concessions on US Army Corp of Engineers-managed lakes, canals, and rivers
Filing targets: Army, Dept of (Corps of Engineers), HOUSE OF REPRESENTATIVES, SENATE
SUNTEX MARINAS via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
Water Resources Development Act of 2026; provisions relating to administration of lease concessions on US Army Corp of Engineers-managed lakes, canals, and rivers
Filing targets: Army, Dept of (Corps of Engineers), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
H.R. 7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
H.R. 7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
Federal policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); Due Process Continuity of Care Act (S. 1720 / H.R. 1510); PEER Support Act (S. 1329 / H.R. 2741); No Red Tape For Addiction Treatment Act (S. 3522); WORK To Save Lives Act (S. 3812 / H.R. 7479). H.R.7148 - Consolidated Appropriations Act, 2026, provisions relating to substance use prevention and treatment funding and policy. FY2027 Labor HHS Appropriations bill (no bill), provisions relating to substance use prevention and treatment funding and policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2026 · first_quarter · Q1
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. S. 4192, PLOT Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture National Farm Security Action Plan, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. U.S Department of Agriculture, Agricultural Foreign Investment Disclosure Act: Revisions to Reporting Requirements NPRM, USDA Docket No. FSA-2024-0005. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
SUNTEX MARINAS via KELLEY DRYE & WARREN LLP
2026 · first_quarter · RR
Water Resources Development Act of 2026; provisions relating to administration of lease concessions on US Army Corp of Engineers-managed lakes, canals, and rivers
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2025 · fourth_quarter · Q4
S.2587/H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; S.2465/H.R.4552, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026, Provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2025 · fourth_quarter · Q4
S.2587/H.R.5304, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; S.2465/H.R.4552, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026, Provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2025 · fourth_quarter · Q4
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); PEER Support Act (H.R. 2741 / S. 1329); No Red Tape For Addiction Treatment Act (S. 3522); and WORK To Save Lives Act (draft legislation in House and Senate); FY2026 appropriations language related to substance use prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2025 · fourth_quarter · Q4
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6209 of the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extension Act, 2026, Pub. L. 119-37, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Section 8001 of H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extension Act, 2026, Pub. L. 119-37, provisions relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139; Federal policy relating to access to mandatory code sets for administrative transactions; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2025 · fourth_quarter · Q4
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2025 · third_quarter · Q3
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (H.R. 2586 / draft Senate bill); H.R. 1510 / S. 1720, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); and H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill); FY2026 appropriations language related to substance use prevention and treatment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2025 · third_quarter · Q3
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill. Federal policy regarding protection of AFIDA filers personal and business confidential information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2025 · third_quarter · Q3
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2025 · third_quarter · Q3
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2025 · third_quarter · Q3
Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to medical laboratory personnel eligibility for the National Health Service Corps and federal grants for lab personnel training; and Federal policy relating to implementation of Medicare reimbursement cuts under the Statutory Pay-As-You-Go Act of 2010, Pub. L. 111-139;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2025 · second_quarter · Q2
Federal Policy relating to substance use prevention and treatment, including: Reentry Act (draft bill); H.R. 1510, Due Process and Continuity of Care Act (whole bill); Modernizing Opioid Treatment Access Act (draft bill); and H.R. 2483, the Support for Patients and Communities Reauthorization Act (whole bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2025 · second_quarter · Q2
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2025 · second_quarter · Q2
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2025 · second_quarter · Q2
Healthcare issues related to clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Section 71120 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to modifying cost sharing requirements for certain expansion individuals under the Medicaid program; H.R. 3514/S.1816, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
Sections 70301, 70302, 70412(b), and 70603 of H.R. 1, An Act to provide for reconciliation pursuant to title II of H. Con. Res. 14, provisions relating to extension of bonus depreciation under Internal Revenue Code Section 168(k), immediate deductibility of domestic research and development expenses under Internal Revenue Code Section 174, individual deductibility of employer-funded tuition assistance under Internal Revenue Code Section 127, and executive compensation under Internal Revenue Code Section 162(m), respectively; Title VII, Subtitle A, Chapter 3, Subchapter B of such Act, provisions relating to treatment of tax credits and reporting simplification under international tax law and guidance; and federal policy relating to income tax rates for corporations and income tax deductibility of corporate state and local taxes
DIGITAL SOVEREIGNTY ALLIANCE (DSA) via KELLEY DRYE & WARREN LLP
2025 · second_quarter · 2T
Federal policy (no bill) relating to the regulation of stablecoins, blockchains, and decentralized autonomous organizations and market structure for digital assets. S.919, GENIUS Act of 2025, provisions relating to regulation of stablecoins. H.R.2392, STABLE Act of 2025, provisions relating to regulation of stablecoins. H.R. 3633, Digital Asset Market Clarity Act of 2025, provisions relating to regulation of stablecoins, blockchains, DAOs and related crypto currency matters. H.R. 2384, Financial Technology Protection Act of 2025, provisions relating to the improvement of anti-money laundering, counter-terrorist, and other counter-illicit financing efforts. Provisions relating to market structure and consumer protection in 118th Congress, including H. R. 4763, FIT 21 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) via KELLEY DRYE & WARREN LLP
2025 · second_quarter · 2T
Federal policy (no bill) relating to the regulation of stablecoins, blockchains, and decentralized autonomous organizations and market structure for digital assets. S.919, GENIUS Act of 2025, provisions relating to regulation of stablecoins. H.R.2392, STABLE Act of 2025, provisions relating to regulation of stablecoins. H.R. 3633, Digital Asset Market Clarity Act of 2025, provisions relating to regulation of stablecoins, blockchains, DAOs and related crypto currency matters. H.R. 2384, Financial Technology Protection Act of 2025, provisions relating to the improvement of anti-money laundering, counter-terrorist, and other counter-illicit financing efforts. Provisions relating to market structure and consumer protection in 118th Congress, including H. R. 4763, FIT 21 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2025 · second_quarter · Q2
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGITAL SOVEREIGNTY ALLIANCE (DSA) via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
Federal policy (no bill) relating to the regulation of stablecoins, blockchains, and decentralized autonomous organizations and market structure for digital assets. S.919, GENIUS Act of 2025, provisions relating to regulation of stablecoins. H.R.2392, STABLE Act of 2025, provisions relating to regulation of stablecoins. H.R. 2384, Financial Technology Protection Act of 2025, provisions relating to the improvement of anti-money laundering, counter-terrorist, and other counter-illicit financing efforts. Provisions relating to market structure and consumer protection in 118th Congress, including H. R. 4763, FIT 21 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
Federal policy (no bill) relating to the regulation of stablecoins, blockchains, and decentralized autonomous organizations and market structure for digital assets. S.919, GENIUS Act of 2025, provisions relating to regulation of stablecoins. H.R.2392, STABLE Act of 2025, provisions relating to regulation of stablecoins. H.R.2032 / S.4912, BITCOIN Act, whole bill. H.R. 2384, Financial Technology Protection Act of 2025, provisions relating to the improvement of anti-money laundering, counter-terrorist, and other counter-illicit financing efforts. H.R. 1664, Deploying American Blockchains Act of 2025, whole bill. Provisions relating to market structure and consumer protection in 118th Congress, including H. R. 4763, FIT 21 Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
S.886 / H.R.1920, FARMLAND Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.1012, SOIL Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978. S.618 / H.R. 1438, Foreign Adversary Risk Management (FARM) Act, provisions relating to reporting requirements under the Agricultural Foreign Investment Disclosure Act of 1978 and electronic filing and public disclosure. S.845/ H.R. 1629, Farmland Security Act of 2025, whole bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NMAC via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
Federal funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; Federal funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
Healthcare issues related to clinical laboratories; Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; Federal policy relating to Medicaid reimbursement for clinical laboratory services; Federal policy relating to prior authorization of services to Medicare Advantage beneficiaries A draft of the Correct Coding Improvement Act, provisions relating to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; and Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
Federal policy relating to federal income tax deductibility of corporate state and local taxes, federal income tax rates for corporations, immediate deductibility of research and development expenses under Internal Revenue Code Section 174, extension of bonus depreciation under Internal Revenue Code Section 168(k), executive compensation under Internal Revenue Code Section 162(m), individual deductibility of employer-funded tuition assistance under Internal Revenue Code Section 127, and appropriate treatment of tax credits and reporting simplification under international tax law and guidance.
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2025 · first_quarter · Q1
General issues relating to substance use prevention and treatment, including: Reentry Act (not yet introduced); Due Process and Continuity of Care Act (H.R. 1510); Modernizing Opioid Treatment Access Act (not yet introduced); the Support for Patients and Communities Reauthorization Act (H.R. 2483); and related provisions in FY25 continuing resolution (H.R. 1968)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGITAL SOVEREIGNTY ALLIANCE (DSA) via KELLEY DRYE & WARREN LLP
2025 · first_quarter · RR
Federal policy regarding blockchain and crypto currency
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · Q4
FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 9029); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY25 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R. 9028), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · Q4
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), and a draft bill for inflation updates to the Medicare Clinical Laboratory Fee Schedule, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests, and other Federal policy relating to FDA oversight of laboratory-developed tests; H.R. 8702/S. 4518, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries, and other Federal policy relating to prior authorization of services to Medicare Advantage beneficiaries; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · 4T
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · Q4
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (H.R. 3074/S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644), and the Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393), and related provisions in FY24 consolidated appropriations bills (H.R. 2882 and H.R. 4366)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · 4T
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · Q4
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2024 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure. FY 2025 USDA/FSA appropriations, provisions relating to funding online AFIDA reporting (no bill number).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) via KELLEY DRYE & WARREN LLP
2024 · fourth_quarter · Q4
Federal policy regarding blockchain and crypto currency; S. 4912, BITCOIN Act of 2024, provisions relating to establishing a federal Bitcoin reserve
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN FUR COUNCIL F/K/A FUR INFORMATION COUNCIL OF AMERICA via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Monitor legislative issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 9029); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY25 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R. 9028), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), Section 301 of H.R. 8261, the Preserving Telehealth, Hospital and Ambulance Access Act, Section 401 of H.R. 7623, the Telehealth Modernization Act, Section 221 of Division B, Title II, Subtitle C of Pub. L. 118-83, 138 Stat. 1524, H.R. 9747, the Continuing Appropriations and Extension Act, 2025, and a draft bill for inflation updates to the Medicare Clinical Laboratory Fee Schedule, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; H.R. 8818, the American Privacy Rights Act, provisions relating to privacy and security of data; H.R. 8702/S. 4518, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; Section 106(b) of H.R. 8261, the Preserving Telehealth, Hospital and Ambulance Access Act, and Section 103(b) of H.R. 7623, the Telehealth Modernization Act, provisions relating to Medicare program integrity for clinical diagnostic laboratory test claims; S. 2140, the Patent Eligibility Restoration Act, provisions relating to patent subject matter eligibility; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (H.R. 3074/S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644), and the Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393), and related provisions in FY24 consolidated appropriations bills (H.R. 2882 and H.R. 4366)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUR COMMISSION USA via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Monitor legislative issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Federal policy regarding blockchain and crypto currency
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2023 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure. FY 2025 USDA/FSA appropriations, provisions relating to funding online AFIDA reporting (no bill number).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · third_quarter · Q3
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TRON BLOCKCHAIN AND DAO (AS SUPPORTED BY TRON TECH LIMITED AND RAINCO PTE LTD.) via KELLEY DRYE & WARREN LLP
2024 · third_quarter · RR
Federal legislation and regulation pertaining to crypto currency and blockchain technology, operations, security and blockchain/DAO operators
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Filing targets: HOUSE OF REPRESENTATIVES
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 9029); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY25 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R. 9028), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), Section 301 of H.R. 8261, the Preserving Telehealth, Hospital and Ambulance Access Act, and Section 201 of H.R. 7623, the Telehealth Modernization Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests; H.R. 8818, the American Privacy Rights Act, provisions relating to privacy and security of data; H.R. 8702/S. 4518, the Improving Seniors Timely Access to Care Act, provisions relating to prior authorization of services to Medicare Advantage beneficiaries; Section 106(b) of H.R. 8261, the Preserving Telehealth, Hospital and Ambulance Access Act, and Section 103(b) of H.R. 7623, the Telehealth Modernization Act, provisions relating to Medicare program integrity for clinical diagnostic laboratory test claims; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development;
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (H.R. 3074/S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644), and the Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393), and related provisions in FY24 consolidated appropriations bills (H.R. 2882 and H.R. 4366)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUR INDUSTRIES OF NORTH AMERICA (FINA) F/K/A FUR WRAPS THE HILL via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
Monitor issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2023 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure. FY 2025 USDA/FSA appropriations, provisions relating to funding online AFIDA reporting (no bill number).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · second_quarter · Q2
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
FY25 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (draft bill); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY25 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (draft bill), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2025 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; Section 102 of H.R. 5378, the Lower Costs, More Transparency Act, and Section 3 of S. 3548, the Health Care Price Transparency Act 2.0, provisions relating to publication of rates for laboratory services; H.R. 7147/S. 3630, the Medicare Transaction Fraud Prevention Act, provisions relating to a Medicare pilot program using predictive risk algorithms to deny certain claims for clinical laboratory services; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (H.R. 3074/S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644), and the Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393), and related provisions in FY24 consolidated appropriations bills (H.R. 2882 and H.R. 4366)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUR INDUSTRIES OF NORTH AMERICA (FINA) F/K/A FUR WRAPS THE HILL via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
Monitor issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2023 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure. FY 2025 USDA/FSA appropriations, provisions relating to funding online AFIDA reporting (no bill number).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2024 · first_quarter · Q1
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (S. 2624); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY24 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R. 4820/S. 2437), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
S. 866, the American Innovation and Jobs Act, and H.R. 2673, the American Innovation and R & D Competitiveness Act, provisions relating to immediate deductibility of research and development expenses under Internal Revenue Code Section 174.
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), and Section 502 of H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; H.R. 3248, the Diagnostic Lab Testing Transparency Act, Section 101 of H.R. 4822, the Health Care Price Transparency Act, Section 102 of H.R. 5378, the Lower Costs, More Transparency Act, Section 105 of H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act, and Section 3 of S. 3548, the Health Care Price Transparency Act 2.0, provisions relating to publication of rates for laboratory services; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644), and the Support for Patients and Communities Reauthorization Act (H.R. 4531/S. 3393)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUR INDUSTRIES OF NORTH AMERICA (FINA) F/K/A FUR WRAPS THE HILL via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
Monitor issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2023 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · fourth_quarter · Q4
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (S. 2624); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY24 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (H.R. 4820/S. 2437), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; H.R. 3791, the Improving DATA in Public Health Act, Section 107 of H.R. 4420, the Preparedness and Response Authorization Act, and H.R. 3742, a bill to direct a GAO study to evaluate the Federal Governments collection and sharing of public health data to respond to public health emergencies, provisions relating to demographic data reporting obligations for laboratories; H.R. 3248, the Diagnostic Lab Testing Transparency Act, Section 101 of H.R. 4822, the Health Care Price Transparency Act, Section 102 of H.R. 5378, the Lower Costs, More Transparency Act, and Section 105 of H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act, provisions relating to publication of rates for laboratory services; A draft of the Correct Coding Improvement Act, provisions related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI), the adoption of Proprietary Laboratory Analysis (PLA) codes, and access to mandatory code sets for administrative transactions; Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Any and all issues related to natural gas exploration and production and gasoline refining, fuels, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FUR INDUSTRIES OF NORTH AMERICA (FINA) F/K/A FUR WRAPS THE HILL via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
Monitor issues related to trade in fur products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting; 2023 Farm Bill (draft bill), provisions related the Agricultural Foreign Investment Disclosure Act; S.2060/H.R.5078, FARMLAND Act, provisions relating to AFIDA disclosure
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · third_quarter · Q3
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP TO END HIV, AIDS & HEPATITIS via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (draft bill); provisions related to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; and expanded access to re-exposure prophylaxis (PrEP) medications and related support; FY24 Transportation, Housing and Urban Development, and Related Agencies Appropriations Act (draft bill), provisions related to funding for the Housing Opportunities for Persons with AIDS Program (HOPWA)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LABORATORY CORPORATION OF AMERICA HOLDINGS via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
Healthcare issues related to clinical laboratories; H.R. 2377/S. 1000, the Saving Access to Laboratory Services Act (SALSA), provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory-developed tests; H.R. 3791, the Improving DATA in Public Health Act, and H.R. 3742, a bill to direct a GAO study to evaluate the Federal Governments collection and sharing of public health data to respond to public health emergencies, provisions relating to demographic data reporting obligations for laboratories; H.R. 3248, the Diagnostic Lab Testing Transparency Act, and Section 105 of H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act, provisions relating to publication of rates for laboratory services; Federal policy related to laboratory procedure coding edits adopted by CMS under the National Correct Coding Initiative (NCCI); Federal policy related to supply chain issues affecting pre-clinical biomedical research for drug development.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXXON MOBIL CORPORATION via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
Any and all issues related to natural gas exploration and production and gasoline refining, and other energy related issues
General issues related to oil and natural gas exploration and production and gasoline refining; federal policy related to carbon capture and storage
Any and all issues related to oil and natural gas exploration and production and gasoline refining, and other energy related issues
Filing targets: HOUSE OF REPRESENTATIVES
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
Amending the Agricultural Foreign Investment Act of 1978; provisions relating to disclosure topics and methods and migration from paper-in-triplicate filings to cloud-based online reporting
Filing targets: HOUSE OF REPRESENTATIVES
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · second_quarter · Q2
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AFIDA MODERNIZATION COMMITTEE (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · second_quarter · RR
Modernizing the Agricultural Foreign Investment Disclosure Act of 1971 to implement and fund the migration of paper filing to online reporting and to enhance disclosure of foreign agricultural land holdings to Congress.
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · first_quarter · 1A
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SMALL BUSINESS CONSTRUCTION AND ENGINEERING COALITION (INFORMAL COALITION) via KELLEY DRYE & WARREN LLP
2023 · first_quarter · Q1
Legislative proposal to establish pilot program to address small business transition issues and DoD shrinking industrial base
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TOBACCO-FREE KIDS ACTION FUND FKA GLOBAL HEALTH ADVOCACY INCUBATOR (GHAI) via KELLEY DRYE & WARREN LLP
2023 · first_quarter · Q1
General issues related to substance use prevention and treatment, including: Reentry Act (H.R. 2400 / S. 1165); Due Process and Continuity of Care Act (S. 971); and Modernizing Opioid Treatment Access Act (H.R. 1359 / S. 644)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Section 201 of H.R. 7024, the Tax Relief for American Families and Workers Act, provisions relating to immediate deductibility of research and development expenses under Internal Revenue Code Section 174.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE